Again, the same confusion and lack of understanding of the post in terms of placebo and crossover. The checkmating 102 will continue until the outstanding results in the JAMA article are grasped. On the otherhand, the post would have no effect on the final outcome with regard to approvals. They will come.
I assume anyone can put comments over there. A medical student put his comments about the paper. A Ph.D. in physics made his comments without disclosure of conflict of interest. I see no reason why you cannot.